These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2246643)

  • 1. Erythromycin tolerance.
    Hahn DL
    J Fam Pract; 1990 Dec; 31(6):668-70. PubMed ID: 2246643
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective comparison of patient tolerance to enteric-coated vs nonenteric-coated erythromycin.
    Ellsworth AJ; Christensen DB; Volpone-McMahon MT
    J Fam Pract; 1990 Sep; 31(3):265-70. PubMed ID: 2202773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and efficacy of erythromycin stearate tablets versus enteric-coated erythromycin base capsules in the treatment of patients with acne vulgaris.
    Bleeker J
    J Int Med Res; 1983; 11(1):38-41. PubMed ID: 6219902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal side effects with erythromycin preparations.
    Carter BL; Woodhead JC; Cole KJ; Milavetz G
    Drug Intell Clin Pharm; 1987 Sep; 21(9):734-8. PubMed ID: 3498618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin in acute pharyngitis: a comparison of efficacy and patient tolerance of two twice-daily preparations.
    Guthrie R
    Clin Ther; 1988; 10(5):530-5. PubMed ID: 2856596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of erythromycin].
    Grym J
    Cesk Pediatr; 1991 May; 46(5):306-7. PubMed ID: 1893476
    [No Abstract]   [Full Text] [Related]  

  • 7. [Release of erythromycin from enteric-coated tablets].
    Chałasińska B; Zakrewski Z
    Acta Pol Pharm; 1985; 42(1):61-7. PubMed ID: 4013800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Erythromycin stearate Spofa--coated tablets for pediatric practice].
    Havlik J; Holý M
    Cesk Pediatr; 1976 Jul; 31(7):402-4. PubMed ID: 963828
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of intestinal amebiasis using erythromycin stearate of normal release with enteric coating (A-16535). Study of 13 cases. Preliminary report].
    Molina Pasquel C; Hernández y Silva J; Rosas M
    Rev Invest Salud Publica; 1967; 27(4):321-6. PubMed ID: 5618959
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of acid protective coating on absorption of erythromycin at oral administration].
    Koroleva VG; Belozerova OP; Vasil'ev VK; Stepnaia VE
    Antibiotiki; 1969 Dec; 14(12):1084-8. PubMed ID: 5371175
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of erythromycin and flucloxacillin in the treatment of infected skin lesions in general practice.
    Baig A; Grillage MG; Welch RB
    Br J Clin Pract; 1988 Mar; 42(3):110-5. PubMed ID: 3207571
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of the clinical testing of an enteric absorbable strophantin].
    Schwarzbach W; Hermstein N
    Med Klin; 1967 Jan; 62(1):15-9. PubMed ID: 6032218
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of erythromycin ethyl succinate in allergic children.
    Crawford LV; Roane J
    Ann Allergy; 1969 Jan; 27(1):18-22. PubMed ID: 5765653
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioavailability and stability of erythromycin delayed release tablets.
    Ogwal S; Xide TU
    Afr Health Sci; 2001 Dec; 1(2):90-6. PubMed ID: 12789122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stability of erythromycin stearate in coated tablets during the action of gastric juice in vitro].
    Pospísilová B; Kubes J
    Cesk Farm; 1987 Mar; 36(2):67-72. PubMed ID: 3581192
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison between 2 preparations forms: slide-effects of prophylactic lithium therapy].
    Laurell B; Persson G
    Lakartidningen; 1970 Jul; 67(27):3083-5. PubMed ID: 4918342
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of nonstreptococcal pharyngitis with erythromycin: a preliminary study.
    Marlow RA; Torrez AJ; Haxby D
    Fam Med; 1989; 21(6):425-7. PubMed ID: 2612797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to erythromycin.
    Eichenwald HF
    Pediatr Infect Dis; 1986; 5(1):147-50. PubMed ID: 3945570
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on absorption of a newly developed enteric-coated erythromycin base.
    McDonald PJ; Mather LE; Story MJ
    J Clin Pharmacol; 1977 Oct; 17(10 Pt 1):601-6. PubMed ID: 915024
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythromycin estolate in general practice. A comparative trial of two dosage forms.
    Grainger GJ
    Practitioner; 1969 Jul; 202(213):84-6. PubMed ID: 4895696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.